The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 15, 2011
Filed:
Oct. 06, 2005
Shenlin Huang, Raritan, NJ (US);
Ronghui Lin, East Brunswick, NJ (US);
Peter J. Connolly, New Providence, NJ (US);
Stuart L. Emanuel, Doylestown, PA (US);
Steven A. Middleton, Flemington, NJ (US);
Robert H. Gruninger, Easton, PA (US);
Steven K. Wetter, Flemington, NJ (US);
Shenlin Huang, Raritan, NJ (US);
Ronghui Lin, East Brunswick, NJ (US);
Peter J. Connolly, New Providence, NJ (US);
Stuart L. Emanuel, Doylestown, PA (US);
Steven A. Middleton, Flemington, NJ (US);
Robert H. Gruninger, Easton, PA (US);
Steven K. Wetter, Flemington, NJ (US);
Janssen Pharmaceutica, N.V., Beerse, BE;
Abstract
1,2,4-Triazolylaminoaryl(heteroaryl)sulfonamide derivatives of formula (I), pharmaceutically acceptable salts thereof, processes for the manufacture of 1,2,4-triazolylaminoaryl(heteroaryl)sulfonamide derivatives and pharmaceutical compositions containing 1,2,4-triazolylaminoaryl(heteroaryl)sulfonamide derivatives are disclosed: The 1,2,4-triazolylaminoaryl(heteroaryl)sulfonamide derivatives of formula (I) possess cell cycle inhibitory activity and are accordingly useful for their anti cell proliferation (such as anti cancer) activity.